With EpiPen competitors bearing down, can Mylan maintain its lead?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 18, 2018 at 4:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via The emergency epinephrine market is about to be flush with options. At least three new epinephrine marketers are challenging Mylan’s EpiPen, the longtime market leader still reeling after a price-hike debacle in 2016 and now dealing with an ongoing manufacturing shortage.

    article source